NCT04328259 is a clinical trial in Inflammatory Bowel Disease Patients, sponsored by Assiut University.

Who is sponsoring NCT04328259?

NCT04328259 is sponsored by Assiut University.

What condition does NCT04328259 study?

NCT04328259 studies Inflammatory Bowel Disease Patients.

Is NCT04328259 still recruiting?

NCT04328259 is currently status unknown. Last updated 20 May 2020.

Last reviewed 2020-05-20 · How we verify

NCT04328259

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevalance of non_ Alcoholic Fatty Liver Diseases in Patient With Inflammatory Bowel Diseases Attending Assiut University Hospitals

Status unknown Last updated 20 May 2020

What this trial tests

trial in Inflammatory Bowel Disease Patients in 30 participants. Status unknown.

Timeline

1 October 2020

Primary endpoint
1 October 2021

1 April 2022

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 October 2020
Primary completion	1 October 2021
Estimated completion	1 April 2022

Conditions studied

Inflammatory Bowel Disease Patients — all drugs for Inflammatory Bowel Disease Patients →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Inflammatory Bowel Disease Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the prevalance of non\_alcoholic fatty liver diseases in inflammatory bowel disease patients and its relation to type of treatment given and disease severity

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04328259 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 20 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04328259.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing